| HIV/AIDS patients (n=301) | |
---|---|---|
Gender ratio (Male: Female) | 1:3.8 | Â |
Mean age, years (range) | 41.3 ±9.3 | (22–75) |
Tobacco smoking | Â | Â |
Yes | 20 | (0.07) |
No | 268 | (0.93) |
Alcohol consumption | Â | Â |
Yes | 29 | (0.10) |
No | 259 | (0.90) |
Mean BMI, kg/m2 (range) | 23.23 ±4.74 | (11.7-40.6) |
Average viral load at baseline, copies/ml (range) | 26917.71 ±27133.50 | (25–98400) |
Average CD4 count at baseline, cells/μl (range) | 136.09 ±113.24 | (2–605) |
Efavirenz-containing ARV regimens | Â | Â |
3TC_TDF_EFV | 9 | (0.03) |
AZT_3TC_EFV | 11 | (0.04) |
d4T_3TC_EFV | 222 | (0.74) |
Average plasma efavirenz concentration, μg/mL (range) | 4.64 | (0.59 – 22) |
Mean Haemoglobin level, IU/l (range) | 11.58 ±2.14 | (5.4-16.3) |
Median AST level, IU/l (range) | 32 | (15 – 228) |
Median ALT level, IU/l (range) | 23.5 | (6 – 176) |
 | Healthy subjects (n=163) | |
Gender ratio (Male: Female) | 1:2.3 | Â |
Mean age, years (range) | 35.8 ±13.96 | (21–63) |
Tobacco smoking | Â | Â |
Yes | 8 | (0.15) |
No | 44 | (0.85) |
Alcohol consumption | Â | Â |
Yes | 22 | (0.42) |
No | 30 | (0.58) |